Sign Up Today and Learn More About PharmaLegacy Laboratories (Shanghai) Co., Ltd. Stock
Invest in or calculate the value of your shares in PharmaLegacy Laboratories (Shanghai) Co., Ltd. or other pre-IPO companies through EquityZen's platform.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Stock (PLLS)
PharmaLegacy Laboratories provides pharmacology services in inflammation and auto-immune diseases.
About PharmaLegacy Laboratories (Shanghai) Co., Ltd. Stock
Founded
2008
Industries
Science and Engineering, Transportation, Health Care
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Press Mentions
Stay in the know about the latest news on PharmaLegacy Laboratories (Shanghai) Co., Ltd.
Preclinical CRO Market Size Projected to Reach USD 13.14 Bn by 2034
biospace • Feb 17, 2025
SHANGHAI OPM BIOSCIENCES CO., LTD.
marketscreener • Jan 17, 2025
Catawba Research Announces Strategic Partnership With PharmaLegacy Laboratories
businesswire • Oct 25, 2024
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Management
Leadership team at PharmaLegacy Laboratories (Shanghai) Co., Ltd.
Member of the Board of Directors
Jeremiah Robins
Join now and verify your accreditation status to gain access to:
- PharmaLegacy Laboratories (Shanghai) Co., Ltd. Current Valuation
- PharmaLegacy Laboratories (Shanghai) Co., Ltd. Stock Price
- PharmaLegacy Laboratories (Shanghai) Co., Ltd. Management
- Available deals in PharmaLegacy Laboratories (Shanghai) Co., Ltd. and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- PharmaLegacy Laboratories (Shanghai) Co., Ltd. Cap Table and Funding History by Share Class and Liquidity Preferences
- PharmaLegacy Laboratories (Shanghai) Co., Ltd. Revenue and Financials
- PharmaLegacy Laboratories (Shanghai) Co., Ltd. Highlights
- PharmaLegacy Laboratories (Shanghai) Co., Ltd. Business Model
- PharmaLegacy Laboratories (Shanghai) Co., Ltd. Risk Factors
- PharmaLegacy Laboratories (Shanghai) Co., Ltd. Research Report from SACRA Research
Trading PharmaLegacy Laboratories (Shanghai) Co., Ltd. Stock
How to invest in PharmaLegacy Laboratories (Shanghai) Co., Ltd. stock?
Accredited investors can buy pre-IPO stock in companies like PharmaLegacy Laboratories (Shanghai) Co., Ltd. through EquityZen funds. These investments are made available by existing PharmaLegacy Laboratories (Shanghai) Co., Ltd. shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell PharmaLegacy Laboratories (Shanghai) Co., Ltd. stock?
Shareholders can sell their PharmaLegacy Laboratories (Shanghai) Co., Ltd. stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
